Catalent Stock EBITDA
Catalent fundamentals help investors to digest information that contributes to Catalent's financial success or failures. It also enables traders to predict the movement of Catalent Stock. The fundamental analysis module provides a way to measure Catalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalent stock.
Catalent |
Catalent Company EBITDA Analysis
Catalent's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Catalent EBITDA | (284 M) |
Most of Catalent's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Catalent reported earnings before interest,tax, depreciation and amortization of (284 Million). This is 132.37% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 107.28% higher than that of the company.
Catalent EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.Catalent is currently under evaluation in ebitda category among its peers.
Catalent Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0018 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 16.13 B | |||
| Shares Outstanding | 181.51 M | |||
| Shares Owned By Insiders | 0.50 % | |||
| Shares Owned By Institutions | 87.80 % | |||
| Number Of Shares Shorted | 14.74 M | |||
| Price To Earning | 17.80 X | |||
| Price To Book | 3.25 X | |||
| Price To Sales | 2.61 X | |||
| Revenue | 4.38 B | |||
| Gross Profit | 1.04 B | |||
| EBITDA | (284 M) | |||
| Net Income | (1.04 B) | |||
| Cash And Equivalents | 345 M | |||
| Cash Per Share | 1.92 X | |||
| Total Debt | 4.92 B | |||
| Debt To Equity | 0.90 % | |||
| Current Ratio | 2.86 X | |||
| Book Value Per Share | 19.52 X | |||
| Cash Flow From Operations | 268 M | |||
| Short Ratio | 7.89 X | |||
| Earnings Per Share | (2.28) X | |||
| Price To Earnings To Growth | 529.00 X | |||
| Target Price | 63.4 | |||
| Number Of Employees | 17 K | |||
| Beta | 1.16 | |||
| Market Capitalization | 11.52 B | |||
| Total Asset | 9.75 B | |||
| Retained Earnings | (781 M) | |||
| Working Capital | 1.57 B | |||
| Current Asset | 790.2 M | |||
| Current Liabilities | 391.2 M | |||
| Net Asset | 9.75 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Catalent Stock
If you are still planning to invest in Catalent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalent's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |